SWM
SRNE

Spire Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Spire Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,000
Closed -$40K – 2716
2022
Q2 		$40K Buy
20,000
+5,000
+33% +$8.64K ﹤0.01% 1387
2022
Q1 		$35K Sell
15,000
-60
-0.4% -$187 ﹤0.01% 1599
2021
Q4 		$70K Hold
15,060
– – ﹤0.01% 1564
2021
Q3 		$115K Hold
15,060
– – ﹤0.01% 1144
2021
Q2 		$146K Sell
15,060
-4,500
-23% -$35.8K ﹤0.01% 1059
2021
Q1 		$162K Buy
+19,560
New +$207K ﹤0.01% 1162

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return